Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53

Lars P. Jordheim, T. Nguyen-Dumont, X. Thomas, C. Dumontet, S. V. Tavtigian

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)


mRNA expression levels of certain genes have shown predictive value for the outcome of cytarabine-treated AML-patients. We hypothesized that genetic variants play a role in the regulation of the transcription of these genes. We studied leukoblasts from 82 patients with acute myeloid leukemia and observed various extent and frequency of differential allelic expression in the CDA, DCK, NT5C2, NT5C3, and TP53 genes. Our attempts to identify the causative regulatory single nucleotide polymorphisms by a bioinformatics approach did not succeed. However, our results indicate that genetic variations are at least in part responsible for the differences in overall expression levels of these genes.

Original languageEnglish
Pages (from-to)2419-2423
Number of pages5
JournalDrug Metabolism and Disposition
Issue number12
Publication statusPublished - Dec 2008
Externally publishedYes

Cite this